Table.
FHL1 mutations and clinical characteristics in X-linked myopathy
Residuea | LIM | Zincb | Inheritc/sex | Onset age | Wheelchair-bound aged | Phenotype/Affected Musclese | CK | Femalesf | Pathologyg | W. Bloth | Ref. |
---|---|---|---|---|---|---|---|---|---|---|---|
C101F | 2nd | Zn1 | SF | 2 | died at 3 | proximal muscles respiratory failure | ↑ | asymp. | RB, RV, AV, pyknotic Nu. IC. of FHL1, α5-integrin, MyHC | ↓ | [5] |
102–104 delKFC | 2nd | Zn1 | SF | 40s | NA | distal muscles | NA | asymp. | RB, RV, IC. of FHL1, α5-integrin, MyHC | ↑ | [5] |
C104R | 2nd | Zn1 | XLD | 10 | no, current 11 | scapuloperoneal Gowers’, rigid spine | ↑ | o.29 wcb.34 | RB IC. of FHL1, α5-integrin, MyHC | ↓ | [5] |
111–229 delG-T | 2nd–4th | Zn1, 2 | XLR | 14 | no, current 35 | scapuloperoneal joints contractures RBBB, respiratory failure | ↑ ↑ | asymp. | non specific myopathic changes | NA | [7] |
W122C* | 2nd | NBS | XLD | 30s | 40s–50s | scapuloperoneal hypertrophy respiratory insufficiency | ↑ | o.73, mild | RV, necrotic, atrophic fibers, IC. of FHL1, desmin, Ub | NA | This report |
W122S* | 2nd | NBS | XLD | 20s | 30s | scapuloperoneal hypertrophy respiratory failure | ↑ | o.30s wcb.50s | NA | ↓ | [2] |
H123Y* | 2nd | Zn1 | SF | <2 | 3 | proximal muscle rigid spine respiratory failure | ↑ | asymp. | RB, IC. of FHL1, desmin, Ub | nl | [1] |
H123Y | 2nd | Zn1 | SF | <1.5 | no, current 2.5 | proximal muscle, neck Gowers’ | mild ↑ | asymp. | RB, RV, IC. of FHL1, pericentrin, tubulin | NA | [6] |
H123L | 2nd | Zn1 | SF | 4 | no, current 7 | generalized hypotrophy scapular Gowers’, scoliosis | nl. | asymp. | RB, RV, IC. of FHL1, pericentrin, tubulin | NA | [6] |
H123Q* | 2nd | Zn1 | SF | 4 | 10 | proximal and axial scapular, scoliosis | ↑ | asymp. | RB, RV, IC. of FHL1, pericentrin, tubulin | NA | [6] |
H123Q | 2nd | Zn1 | SF | 3 | 8 | neck, axial Gowers’, scoliosis respiratory insufficiency | ↑ ↑ | asymp. | RB, RV, IC. of FHL1, pericentrin, tubulin | NA | [6] |
H123Q | 2nd | Zn1 | SM | 1 | 2 | proximal, scoliosis cardiomyopathy, respiratory insufficiency | ↑ ↑ | asymp. | RB, RV, IC. of FHL1, pericentrin, tubulin | NA | [6] |
K124Rfs X6 | 2nd | Zn1, 2 | XLD | 10 | no, current 26 | humeral, peroneal, facial JC, RBBB, AFb | ↑ | NA | dystrophic | ↓ | [7] |
127–128in sFT | 2nd | NBS | XLR | 30s–40s | 50s | postural, hypertrophy respiratory failure | ↑ ↑ | asymp. | Atrophy and necrotic fibers. Variation in fiber size | NA | [3] |
C132F* | 2nd | Zn1 | SF | 2 | 4.5, died at 6.5 | generalized hypotrophy respiratory failure | ↑ | asymp. | RB, IC. of FHL1, desmin, Ub | ↑ | [1] |
C150Y* | 2nd | Zn2 | SF | 2.5 | died at 4.5 | proximal muscles respiratory failure | mild ↑ | asymp. | RB, RV, AV, pyknotic Nu. | NA | [5] |
151–153 delVTC | 2nd | Zn2 | SM? | 13 | no, current 16 | scapuloperoneal, rigid spine, Gowers’ | mild ↑ | asymp. | RB, RV, increased FHL1staining | ↓ | [4] |
C153R | 2nd | Zn2 | XLD | 5 | 8 | proximal, cardiomyopathy respiratory insufficiency | ↑ ↑ | o.30s wcb.40s | RB | NA | [1] |
C153Y | 2nd | Zn2 | XLD | 10 | 16 | proximal muscles rigid spine | ↑ | o.30s | RB | NA | [1] |
K157Vfs X36 | 2nd | Zn1, 2 | XLD | 4 | no, current 23 | scapuloperoneal, facial, JC, heart hypertrophy | ↑ | cardiac disease | non specific myopathic changes | ↓ | [7] |
A168Gfs X27 | 2nd | Zn1, 2 | XLD | 20s | NA | rigid spine, sinus valsalvae aneurysm | ↑ ↑ | o. 50s | protein body, loss of FHL1 staining | absent | [8] |
C209R | 3rd | Zn2 | XLD | 11 | no, current 41 | scapular, pelvic, JC arrhythmias | ↑ ↑ | o.10to69 | dystrophic changes | ↓ | [7] |
C224W | 4th | Zn1 | XLR | 30s | died at 45–72 | postural, scapulo-axio-peroneal, hypertrophy cardiomyopathy respiratory failure | ↑ or ↑ ↑ | asymp. | core-like in NADH, AV FHL1 absent or reduced staining | absent | [3] |
C224W | 4th | Zn1 | XLR/XLD | 6–45 | NA | rigid spine, hypertrophy scapuloperoneal respiratory failure | ↑ | asymp. | absent FHL1 staining | absent | [8] |
H246Y | 4th | Zn1 | SM? | 17 | NA | rigid spine, scapuloperoneal | mild ↑ | asymp. | hypertrophy, FHL1 no staining | NA | [8] |
C273Lfs X11 | 4th | Zn2 | XLD | 6 | no, current 30 | scapular, pelvic hypertrophy, JC | ↑ | cardiac disease | non specific myopathic changes | NA | [7] |
C276Y | 4th | Zn2 | XLR | 48 | no, current 54 | axial, pelvic, hypertrophy JC, AFb, AFI | ↑ | asymp | dystrophic/myopathic reduced FHL1 staining | ↓ | [7] |
V280M | 4th | NBS | XLR | 8 | NA | rigid spine, scapuloperoneal | ↑ | asymp | absent FHL1 staining | absent | [8] |
X281E | 4th | NBS | XLR | 10 | no, current 18 | Scapuloperoneal, JC septal hypertrophy | ↑ | asymp | dystrophic reduced FHL1 staining | ↓ | [7] |
Notes:
* = mutations studied in molecular dynamics simulations; ins = in-frame nucleotide insertion; del = in-frame nucleotide deletion; fsX = frameshifting mutation, with the following number indicating the number of new amino acids downstream of the mutation preceding introduction of a premature stop codon.
Binding to the first or second Zn of the domain; NBS = not a binding site.
Inheritance pattern: SF = sporadic female; SM = sporadic male; XLD = X-linked dominant; XLR = X-linked recessive.
Age (years) at which patient became wheel-chair bound or died, or current age if still ambulatory; NA=not available
JC = joint contractures; RBBB = right bundle branch block; AFb = atrial fibrillation; AFI = atrial flutter
Myopathy symptoms in female members: o = age of onset; wcb = age at which wheelchair bound; asymp = asymptomatic.
RB = reducing bodies; RV = rimmed vacuoles; AV = autophagy vacuoles; Nu = nucleus; IC = inclusion; Ub = ubiquitin;
FHL1 expression level by western blot; nl = normal.